Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-17-018533

Director sold 8,580 shares at an average $41.49 ($355,982)

  • Director acquired 8,580 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KROLL MARK W Director 2017-05-15 Option exercise +8,580 $27.24 $233,719 31,014 D
KROLL MARK W Director 2017-05-15 Sale −100 $41.44 $4,144 30,914 D
KROLL MARK W Director 2017-05-15 Sale −100 $41.45 $4,145 30,814 D
KROLL MARK W Director 2017-05-15 Sale −200 $41.45 $8,290 30,614 D
KROLL MARK W Director 2017-05-15 Sale −53 $41.45 $2,197 30,561 D
KROLL MARK W Director 2017-05-15 Sale −100 $41.46 $4,146 30,461 D
KROLL MARK W Director 2017-05-15 Sale −500 $41.46 $20,730 29,961 D
KROLL MARK W Director 2017-05-15 Sale −300 $41.47 $12,440 29,661 D
KROLL MARK W Director 2017-05-15 Sale −1,771 $41.47 $73,443 27,890 D
KROLL MARK W Director 2017-05-15 Sale −300 $41.48 $12,443 27,590 D
KROLL MARK W Director 2017-05-15 Sale −1,900 $41.48 $78,812 25,690 D
KROLL MARK W Director 2017-05-15 Sale −300 $41.49 $12,446 25,390 D
KROLL MARK W Director 2017-05-15 Sale −100 $41.49 $4,149 25,290 D
KROLL MARK W Director 2017-05-15 Sale −100 $41.50 $4,150 25,190 D
KROLL MARK W Director 2017-05-15 Sale −453 $41.50 $18,800 24,737 D
KROLL MARK W Director 2017-05-15 Sale −276 $41.51 $11,455 24,461 D
KROLL MARK W Director 2017-05-15 Sale −818 $41.52 $33,963 23,643 D
KROLL MARK W Director 2017-05-15 Sale −129 $41.53 $5,357 23,514 D
KROLL MARK W Director 2017-05-15 Sale −273 $41.54 $11,340 23,241 D
KROLL MARK W Director 2017-05-15 Sale −100 $41.55 $4,155 23,141 D
KROLL MARK W Director 2017-05-15 Sale −400 $41.55 $16,620 22,741 D
KROLL MARK W Director 2017-05-15 Sale −307 $41.56 $12,759 22,434 D
Derivatives
KROLL MARK W Director 2017-05-15 Option exercise · Non-qualified Stock Option (Right to Buy) −8,580 0 D
Open-market sales · 8,580 sh · avg $41.49 · $355,982
Loading xslF345X03/form4.xml…